Biologics are the pharmaceuticals of the future. Instead of by chemical synthesis, they are produced in living organisms such as bacterial cells. Wacker Biotech’s technology turns bacteria into tiny pharmaceutical factories producing large quantities of extraordinarily high-quality actives at acceptable prices. This unique science is in demand among pharmaceutical companies the world over. The market for biologics is growing, and Wacker Biotech is growing right along with it.